Guggenheim analyst Robert Drbul downgrades Allbirds (NASDAQ:BIRD) from Buy to Neutral.
First Patient Enrolled In SeaStar Medical’s Pivotal Clinical Trial With The Selective Cytopheretic Device In Adults With Acute Kidney Injury
SeaStar Medical Holding Corporation (NASDAQ:ICU), a medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, announces enrollment of the first
